MDAT

From Self-sufficiency
Revision as of 09:40, 27 July 2010 by Reconsider the static (Talk) (Reverted edits by 24.64.81.15 (talk) to last version by SmackBot)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
MDAT
File:6,7-Methylenedioxy-2-aminotetralin2.png
Systematic (IUPAC) name
5,6,7,8-tetrahydrobenzo[f][1,3]benzodioxol-7-amine
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • Uncontrolled
Identifiers
CAS Number 101625-35-8 freebase
33446-21-8 hydrochloride salt
ATC code none
PubChem CID 36483
ChemSpider 33531
Chemical data
Formula C11H13NO2
Molar mass 191.223 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

6,7-Methylenedioxy-2-aminotetralin (MDAT) is a drug developed in the 1990s by a team at Purdue University led by David E. Nichols.[1] It appears to act as a serotonin releasing agent based on rodent drug discrimination assays comparing it to MDMA, in which it fully substitutes for, and additionally lacks any kind of serotonergic neurotoxicity.[1] Hence, MDAT is a non-neurotoxic, putative entactogen in humans.

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />
  1. 1.0 1.1 Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.